# EDGAR Filing Document

**Accession Number:** 0001100663
**File Stem:** 0001752724-25-204465
**Filing Date:** 2025-8
**Character Count:** 62759
**Document Hash:** fe0c552fa8a2071622c8ce151d63b0f0
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001752724-25-204465.hdr.sgml**: 20250826

**ACCESSION NUMBER**: 0001752724-25-204465

**CONFORMED SUBMISSION TYPE**: NPORT-P

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20250630

**FILED AS OF DATE**: 20250826

**DATE AS OF CHANGE**: 20250826

**PERIOD START**: 20260331

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** iSHARES TRUST
- **CENTRAL INDEX KEY:** 0001100663

**ORGANIZATION NAME:**
- **EIN:** 943351276
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** NPORT-P
- **SEC ACT:** 1940 Act
- **SEC FILE NUMBER:** 811-09729
- **FILM NUMBER:** 251254619

**BUSINESS ADDRESS:**
- **STREET 1:** 400 HOWARD STREET
- **CITY:** SAN FRANCISCO
- **STATE:** CA
- **ZIP:** 94105
- **BUSINESS PHONE:** (415) 670-2000

**MAIL ADDRESS:**
- **STREET 1:** 400 HOWARD STREET
- **CITY:** SAN FRANCISCO
- **STATE:** CA
- **ZIP:** 94105

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** ISHARES TRUST
- **DATE OF NAME CHANGE:** 19991213

## Series and Classes Contracts Data

### iShares Global Healthcare ETF (Series ID: S000004372)

| Class ID   | Class Name                    | Ticker Symbol   |
|:---|:---|:---|
| C000012102 | iShares Global Healthcare ETF | IXJ             |

## Nport-Ex

Schedule of Investments (unaudited)

June 30, 2025

**iShares® Global Healthcare ETF**

**(Percentages shown are based on Net Assets)**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | |
|:---|:---|:---|
| *Security* | &nbsp;&nbsp; *Shares* | *Value* |
| **Common Stocks** | **Common Stocks** | **Common Stocks** |
| **Australia — 1.7%** | **Australia — 1.7%** | **Australia — 1.7%** |
| Cochlear Ltd. | &nbsp;&nbsp;&nbsp; 34967 | $6915635 |
| CSL Ltd. | &nbsp;&nbsp;&nbsp; 258772 | 40875770 |
| Pro Medicus Ltd. | &nbsp;&nbsp;&nbsp; 29211 | 5466390 |
| Sigma Healthcare Ltd. | &nbsp;&nbsp;&nbsp; 3082980 | 6068216 |
| Sonic Healthcare Ltd. | &nbsp;&nbsp;&nbsp; 257356 | 4542639 |
|  |  | 63868650 |
| **Belgium — 0.8%** | **Belgium — 0.8%** | **Belgium — 0.8%** |
| Argenx SE<sup>(a)</sup> | &nbsp;&nbsp;&nbsp; 32472 | 17975938 |
| UCB SA | &nbsp;&nbsp;&nbsp; 64388 | 12668840 |
|  |  | 30644778 |
| **Brazil — 0.1%** | **Brazil — 0.1%** | **Brazil — 0.1%** |
| Rede D'Or Sao Luiz SA<sup>(b)</sup> | &nbsp;&nbsp;&nbsp; 576659 | 3759412 |
| **Denmark — 3.5%** | **Denmark — 3.5%** | **Denmark — 3.5%** |
| Coloplast A/S, Class B | &nbsp;&nbsp;&nbsp; 66672 | 6347369 |
| Genmab A/S<sup>(a)</sup> | &nbsp;&nbsp;&nbsp; 35578 | 7388426 |
| Novo Nordisk A/S, Class B | &nbsp;&nbsp;&nbsp; 1689190 | 117050746 |
| Zealand Pharma A/S<sup>(a)(c)</sup> | &nbsp;&nbsp;&nbsp; 34102 | 1912512 |
|  |  | 132699053 |
| **France — 2.8%** | **France — 2.8%** | **France — 2.8%** |
| EssilorLuxottica SA | &nbsp;&nbsp;&nbsp; 154036 | 42297163 |
| Eurofins Scientific SE | &nbsp;&nbsp;&nbsp; 68999 | 4917236 |
| Sanofi SA | &nbsp;&nbsp;&nbsp; 571514 | 55330417 |
| Sartorius Stedim Biotech | &nbsp;&nbsp;&nbsp; 14087 | 3370491 |
|  |  | 105915307 |
| **Germany — 1.5%** | **Germany — 1.5%** | **Germany — 1.5%** |
| Bayer AG, Registered | &nbsp;&nbsp;&nbsp; 525034 | 15817860 |
| Fresenius Medical Care AG | &nbsp;&nbsp;&nbsp; 107028 | 6149310 |
| Fresenius SE & Co. KGaA | &nbsp;&nbsp;&nbsp; 223629 | 11253636 |
| Merck KGaA | &nbsp;&nbsp;&nbsp; 69070 | 8955506 |
| QIAGEN NV | &nbsp;&nbsp;&nbsp; 117031 | 5638511 |
| Siemens Healthineers AG<sup>(b)</sup> | &nbsp;&nbsp;&nbsp; 162764 | 9035737 |
|  |  | 56850560 |
| **Japan — 4.2%** | **Japan — 4.2%** | **Japan — 4.2%** |
| Astellas Pharma Inc. | &nbsp;&nbsp;&nbsp; 967075 | 9468584 |
| Chugai Pharmaceutical Co. Ltd. | &nbsp;&nbsp;&nbsp; 340800 | 17795833 |
| Daiichi Sankyo Co. Ltd. | &nbsp;&nbsp;&nbsp; 1019700 | 23624496 |
| Eisai Co. Ltd. | &nbsp;&nbsp;&nbsp; 152600 | 4382736 |
| Hoya Corp. | &nbsp;&nbsp;&nbsp; 184800 | 21947233 |
| M3 Inc. | &nbsp;&nbsp;&nbsp; 229200 | 3148452 |
| Olympus Corp. | &nbsp;&nbsp;&nbsp; 604400 | 7179257 |
| Ono Pharmaceutical Co. Ltd. | &nbsp;&nbsp;&nbsp; 248200 | 2689934 |
| Otsuka Holdings Co. Ltd. | &nbsp;&nbsp;&nbsp; 280200 | 13892117 |
| Shionogi & Co. Ltd. | &nbsp;&nbsp;&nbsp; 431000 | 7758981 |
| Sysmex Corp. | &nbsp;&nbsp;&nbsp; 260000 | 4525873 |
| Takeda Pharmaceutical Co. Ltd. | &nbsp;&nbsp;&nbsp; 850092 | 26244876 |
| Terumo Corp. | &nbsp;&nbsp;&nbsp; 791200 | 14519995 |
|  |  | 157178367 |
| **Netherlands — 0.3%** | **Netherlands — 0.3%** | **Netherlands — 0.3%** |
| Koninklijke Philips NV | &nbsp;&nbsp;&nbsp; 426022 | 10229790 |
| **South Korea — 0.5%** | **South Korea — 0.5%** | **South Korea — 0.5%** |
| Celltrion Inc. | &nbsp;&nbsp;&nbsp; 83103 | 9806149 |
| Samsung Biologics Co. Ltd.<sup>(a)(b)</sup> | &nbsp;&nbsp;&nbsp; 9855 | 7231772 |
|  |  | 17037921 |
| **Spain — 0.0%** | **Spain — 0.0%** | **Spain — 0.0%** |
| Grifols SA<sup>(a)</sup> | &nbsp;&nbsp;&nbsp; 154655 | 1887098 |
| **Sweden — 0.1%** | **Sweden — 0.1%** | **Sweden — 0.1%** |
| Getinge AB, Class B | &nbsp;&nbsp;&nbsp; 117132 | 2353267 |

---

---

| | | |
|:---|:---|:---|
| *Security* | &nbsp;&nbsp; *Shares* | *Value* |
| **Switzerland — 9.1%** | **Switzerland — 9.1%** | **Switzerland — 9.1%** |
| Alcon AG | &nbsp;&nbsp;&nbsp; 267053 | $23683039 |
| Galderma Group AG | &nbsp;&nbsp;&nbsp; 62457 | 9078480 |
| Lonza Group AG, Registered | &nbsp;&nbsp;&nbsp; 38599 | 27604594 |
| Novartis AG, Registered | &nbsp;&nbsp;&nbsp; 1018636 | 123639080 |
| Roche Holding AG, Bearer | &nbsp;&nbsp;&nbsp; 15482 | 5380476 |
| Roche Holding AG, NVS | &nbsp;&nbsp;&nbsp; 376427 | 122873173 |
| Sandoz Group AG | &nbsp;&nbsp;&nbsp; 235146 | 12886795 |
| Sonova Holding AG, Registered | &nbsp;&nbsp;&nbsp; 26604 | 7933989 |
| Straumann Holding AG | &nbsp;&nbsp;&nbsp; 63433 | 8302727 |
|  |  | 341382353 |
| **United Kingdom — 5.1%** | **United Kingdom — 5.1%** | **United Kingdom — 5.1%** |
| AstraZeneca PLC | &nbsp;&nbsp;&nbsp; 830819 | 115624362 |
| GSK PLC | &nbsp;&nbsp;&nbsp; 2215702 | 42245583 |
| Haleon PLC | &nbsp;&nbsp;&nbsp; 4815178 | 24748214 |
| Smith & Nephew PLC | &nbsp;&nbsp;&nbsp; 467299 | 7156322 |
|  |  | 189774481 |
| **United States — 69.8%** | **United States — 69.8%** | **United States — 69.8%** |
| Abbott Laboratories | &nbsp;&nbsp;&nbsp; 932190 | 126787162 |
| AbbVie Inc. | &nbsp;&nbsp;&nbsp; 946424 | 175675223 |
| Agilent Technologies Inc. | &nbsp;&nbsp;&nbsp; 152465 | 17992395 |
| Align Technology Inc.<sup>(a)</sup> | &nbsp;&nbsp;&nbsp; 37066 | 7017706 |
| Amgen Inc. | &nbsp;&nbsp;&nbsp; 287096 | 80160074 |
| Baxter International Inc. | &nbsp;&nbsp;&nbsp; 271701 | 8227106 |
| Becton Dickinson & Co. | &nbsp;&nbsp;&nbsp; 153451 | 26431935 |
| Biogen Inc.<sup>(a)</sup> | &nbsp;&nbsp;&nbsp; 77941 | 9788610 |
| Bio-Techne Corp. | &nbsp;&nbsp;&nbsp; 83949 | 4319176 |
| Boston Scientific Corp.<sup>(a)</sup> | &nbsp;&nbsp;&nbsp; 792675 | 85141222 |
| Bristol-Myers Squibb Co. | &nbsp;&nbsp;&nbsp; 1090379 | 50473644 |
| Cardinal Health Inc. | &nbsp;&nbsp;&nbsp; 129100 | 21688800 |
| Cencora Inc. | &nbsp;&nbsp;&nbsp; 92233 | 27656065 |
| Centene Corp.<sup>(a)</sup> | &nbsp;&nbsp;&nbsp; 264667 | 14366125 |
| Charles River Laboratories International Inc.<sup>(a)(c)</sup> | &nbsp;&nbsp;&nbsp; 27688 | 4201100 |
| Cigna Group (The) | &nbsp;&nbsp;&nbsp; 143133 | 47316907 |
| Cooper Companies Inc. (The)<sup>(a)</sup> | &nbsp;&nbsp;&nbsp; 107206 | 7628779 |
| CVS Health Corp. | &nbsp;&nbsp;&nbsp; 676865 | 46690148 |
| Danaher Corp. | &nbsp;&nbsp;&nbsp; 342032 | 67565001 |
| DaVita Inc.<sup>(a)</sup> | &nbsp;&nbsp;&nbsp; 23513 | 3349427 |
| Dexcom Inc.<sup>(a)</sup> | &nbsp;&nbsp;&nbsp; 208800 | 18226152 |
| Edwards Lifesciences Corp.<sup>(a)</sup> | &nbsp;&nbsp;&nbsp; 315204 | 24652105 |
| Elevance Health Inc. | &nbsp;&nbsp;&nbsp; 121055 | 47085553 |
| Eli Lilly & Co. | &nbsp;&nbsp;&nbsp; 421090 | 328252288 |
| GE HealthCare Technologies Inc., NVS<sup>(a)</sup> | &nbsp;&nbsp;&nbsp; 244392 | 18102115 |
| Gilead Sciences Inc. | &nbsp;&nbsp;&nbsp; 666036 | 73843411 |
| HCA Healthcare Inc. | &nbsp;&nbsp;&nbsp; 92806 | 35553979 |
| Henry Schein Inc.<sup>(a)(c)</sup> | &nbsp;&nbsp;&nbsp; 67107 | 4902166 |
| Hologic Inc.<sup>(a)</sup> | &nbsp;&nbsp;&nbsp; 119259 | 7770916 |
| Humana Inc. | &nbsp;&nbsp;&nbsp; 64472 | 15762115 |
| IDEXX Laboratories Inc.<sup>(a)(c)</sup> | &nbsp;&nbsp;&nbsp; 43761 | 23470775 |
| Incyte Corp.<sup>(a)</sup> | &nbsp;&nbsp;&nbsp; 86355 | 5880776 |
| Insulet Corp.<sup>(a)</sup> | &nbsp;&nbsp;&nbsp; 37485 | 11777037 |
| Intuitive Surgical Inc.<sup>(a)(c)</sup> | &nbsp;&nbsp;&nbsp; 192037 | 104354826 |
| IQVIA Holdings Inc.<sup>(a)</sup> | &nbsp;&nbsp;&nbsp; 89406 | 14089492 |
| Johnson & Johnson | &nbsp;&nbsp;&nbsp; 1289154 | 196918274 |
| Labcorp Holdings Inc. | &nbsp;&nbsp;&nbsp; 44571 | 11700333 |
| McKesson Corp. | &nbsp;&nbsp;&nbsp; 66976 | 49078673 |
| Medtronic PLC | &nbsp;&nbsp;&nbsp; 685286 | 59736381 |
| Merck & Co. Inc. | &nbsp;&nbsp;&nbsp; 1345390 | 106501072 |
| Mettler-Toledo International Inc.<sup>(a)</sup> | &nbsp;&nbsp;&nbsp; 11176 | 13128671 |
| Moderna Inc.<sup>(a)(c)</sup> | &nbsp;&nbsp;&nbsp; 180977 | 4993155 |
| Molina Healthcare Inc.<sup>(a)</sup> | &nbsp;&nbsp;&nbsp; 29578 | 8811286 |
| Pfizer Inc. | &nbsp;&nbsp;&nbsp; 3046172 | 73839209 |

---

------

Schedule of Investments (unaudited)(continued)

June 30, 2025

**iShares® Global Healthcare ETF**

**(Percentages shown are based on Net Assets)**

---

| | | |
|:---|:---|:---|
| *Security* | &nbsp;&nbsp; *Shares* | *Value* |
| **United States (continued)** | **United States (continued)** | **United States (continued)** |
| Quest Diagnostics Inc. | &nbsp;&nbsp;&nbsp; 59321 | $10655831 |
| Regeneron Pharmaceuticals Inc. | &nbsp;&nbsp;&nbsp; 56225 | 29518125 |
| ResMed Inc. | &nbsp;&nbsp;&nbsp; 78490 | 20250420 |
| Revvity Inc. | &nbsp;&nbsp;&nbsp; 65522 | 6337288 |
| Solventum Corp.<sup>(a)(c)</sup> | &nbsp;&nbsp;&nbsp; 74402 | 5642648 |
| STERIS PLC | &nbsp;&nbsp;&nbsp; 52508 | 12613472 |
| Stryker Corp. | &nbsp;&nbsp;&nbsp; 183532 | 72610765 |
| Thermo Fisher Scientific Inc. | &nbsp;&nbsp;&nbsp; 202258 | 82007529 |
| UnitedHealth Group Inc. | &nbsp;&nbsp;&nbsp; 486038 | 151629275 |
| Universal Health Services Inc., Class B | &nbsp;&nbsp;&nbsp; 31607 | 5725608 |
| Vertex Pharmaceuticals Inc.<sup>(a)</sup> | &nbsp;&nbsp;&nbsp; 137235 | 61097022 |
| Viatris Inc. | &nbsp;&nbsp;&nbsp; 641810 | 5731363 |
| Waters Corp.<sup>(a)</sup> | &nbsp;&nbsp;&nbsp; 31731 | 11075388 |
| West Pharmaceutical Services Inc. | &nbsp;&nbsp;&nbsp; 38896 | 8510445 |
| Zimmer Biomet Holdings Inc. | &nbsp;&nbsp;&nbsp; 106130 | 9680117 |
| Zoetis Inc. | &nbsp;&nbsp;&nbsp; 239311 | 37320550 |
|  |  | 2621313211 |
| **Total Common Stocks — 99.5%** <br>**(Cost: $3,405,139,463)** | **Total Common Stocks — 99.5%** <br>**(Cost: $3,405,139,463)** | 3734894248 |
| **Preferred Stocks** | **Preferred Stocks** | **Preferred Stocks** |
| **Germany — 0.1%** | **Germany — 0.1%** | **Germany — 0.1%** |
| Sartorius AG, Preference Shares, NVS | &nbsp;&nbsp;&nbsp; 13018 | 3315657 |
| **Total Preferred Stocks — 0.1%** <br>**(Cost: $4,513,941)** | **Total Preferred Stocks — 0.1%** <br>**(Cost: $4,513,941)** | 3315657 |
| **Total Long-Term Investments — 99.6%** <br>**(Cost: $3,409,653,404)** | **Total Long-Term Investments — 99.6%** <br>**(Cost: $3,409,653,404)** | 3738209905 |

---

---

| | | |
|:---|:---|:---|
| *Security* | &nbsp;&nbsp; *Shares* | *Value* |
| **Short-Term Securities** | **Short-Term Securities** | **Short-Term Securities** |
| **Money Market Funds — 0.5%** | **Money Market Funds — 0.5%** | **Money Market Funds — 0.5%** |
| &nbsp;&nbsp;&nbsp; BlackRock Cash Funds: Institutional, SL Agency <br> Shares, 4.47%<sup>(d)(e)(f)</sup><br>| &nbsp;&nbsp;&nbsp; 15025749 | $15031759 |
| &nbsp;&nbsp;&nbsp; BlackRock Cash Funds: Treasury, SL Agency Shares, <br> 4.30%<sup>(d)(e)</sup><br>| &nbsp;&nbsp;&nbsp; 5880000 | 5880000 |
| **Total Short-Term Securities — 0.5%** <br>**(Cost: $20,910,390)** | **Total Short-Term Securities — 0.5%** <br>**(Cost: $20,910,390)** | 20911759 |
| **Total Investments — 100.1%** <br>**(Cost: $3,430,563,794)** | **Total Investments — 100.1%** <br>**(Cost: $3,430,563,794)** | 3759121664 |
| **Liabilities in Excess of Other Assets — (0.1)%** | **Liabilities in Excess of Other Assets — (0.1)%** | (4792590)<br>|
| **Net Assets — 100.0%** | **Net Assets — 100.0%** | $3754329074 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

<sup>(a)</sup> Non-income producing security.

<sup>(b)</sup> Security exempt from registration pursuant to Rule 144A under the Securities Act of 1933, as amended. These securities may be resold in transactions exempt from registration to qualified institutional investors. 

<sup>(c)</sup> All or a portion of this security is on loan.

<sup>(d)</sup> Affiliate of the Fund.

<sup>(e)</sup> Annualized 7-day yield as of period end.

<sup>(f)</sup> All or a portion of this security was purchased with the cash collateral from loaned securities. 

**Affiliates**

Investments in issuers considered to be affiliate(s) of the Fund during the period ended June 30, 2025 for purposes of Section 2(a)(3) of the Investment Company Act of 1940, as amended, were as follows:

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| *Affiliated Issuer* | *Value at* <br>*03/31/25*<br>| &nbsp;&nbsp; *Proceeds* <br>*from Sales*<br>| *Net Realized* <br>*Gain (Loss)*<br>| *Change in* <br>*Unrealized* <br>*Appreciation* <br>*(Depreciation)*<br>| *Value at* <br>*06/30/25*<br>| *Shares* <br>*Held at* <br>*06/30/25*<br>| *Income* | &nbsp;&nbsp; *Capital* <br>*Gain* <br>*Distributions* <br>*from* <br>*Underlying* <br>*Funds*<br>|
| &nbsp;&nbsp;&nbsp; BlackRock Cash Funds: Institutional, SL Agency <br> Shares<br>| $7962449<br> $7072487 <br><sup>(a)</sup><br>| $— | $(3769)<br>| $593 | $15031759 | 15025749 | $31586 <br><sup>(b)</sup><br>| $— |
| &nbsp;&nbsp;&nbsp; BlackRock Cash Funds: Treasury, SL Agency <br> Shares<br>| &nbsp;&nbsp; 3820000<br> 2060000 <br><sup>(a)</sup><br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — | &nbsp;&nbsp;&nbsp; 5880000 | 5880000 | &nbsp;&nbsp; 59610 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; — |
|  |  |  | $(3769) | $593 | $20911759 |  | $91196 | $— |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

<sup>(a)</sup> Represents net amount purchased (sold).

<sup>(b)</sup> All or a portion represents securities lending income earned from the reinvestment of cash collateral from loaned securities, net of collateral investment fees, and other payments to and from borrowers of securities. 

------

Schedule of Investments (unaudited)(continued)

June 30, 2025

**iShares® Global Healthcare ETF**

**Derivative Financial Instruments Outstanding as of Period End**

**Futures Contracts** 

---

| | | | | |
|:---|:---|:---|:---|:---|
| *Description* | &nbsp;&nbsp; *Number of* <br>*Contracts*<br>| &nbsp;&nbsp; *Expiration* <br>*Date*<br>| *Notional* <br>*Amount* <br>*(000)*<br>| &nbsp;&nbsp; *Value/* <br>*Unrealized* <br>*Appreciation* <br>*(Depreciation)*<br>|
| Long Contracts |  |  |  |  |
| &nbsp;&nbsp;&nbsp; E-Mini Health Care Select Sector Index | &nbsp;&nbsp;&nbsp; 113 | 09/19/25 | &nbsp;&nbsp; $15505 | $(64667) |

---

**Fair Value Hierarchy as of Period End** 

Various inputs are used in determining the fair value of financial instruments at the measurement date. These inputs to valuation techniques are categorized into a fair value hierarchy consisting of three broad levels for financial reporting purposes as follows:

• Level 1 – Unadjusted price quotations in active markets/exchanges that the Fund has the ability to access for identical assets or liabilities;

• Level 2 – Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Level 3 – Inputs that are unobservable and significant to the entire fair value measurement for the asset or liability (including the Valuation Committee's assumptions used in determining the fair value of financial instruments).

The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). Accordingly, the degree of judgment exercised in determining fair value is greatest for instruments categorized in Level 3. The inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, for disclosure purposes, the fair value hierarchy classification is determined based on the lowest level input that is significant to the fair value measurement in its entirety. Investments classified within Level 3 have significant unobservable inputs used by the Valuation Committee in determining the price for Fair Valued Investments. Level 3 investments include equity or debt issued by privately held companies or funds that may not have a secondary market and/or may have a limited number of investors. The categorization of a value determined for financial instruments is based on the pricing transparency of the financial instruments and is not necessarily an indication of the risks associated with investing in those securities. For information about the Fund's policy regarding valuation of financial instruments, refer to its most recent financial statements.

The following table summarizes the Fund's financial instruments categorized in the fair value hierarchy. The breakdown of the Fund's financial instruments into major categories is disclosed in the Schedule of Investments above.

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | *Level 1* | *Level 2* | *Level 3* | *Total* |
| Assets  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Investments  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Long-Term Investments  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Common Stocks | &nbsp;&nbsp; $2625072623 | &nbsp;&nbsp; $1109821625 | &nbsp;&nbsp; $— | &nbsp;&nbsp; $3734894248 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Preferred Stocks | &nbsp;&nbsp; — | &nbsp;&nbsp; 3315657 | &nbsp;&nbsp; — | &nbsp;&nbsp; 3315657 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Short-Term Securities  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Money Market Funds | &nbsp;&nbsp; 20911759 | &nbsp;&nbsp; — | &nbsp;&nbsp; — | &nbsp;&nbsp; 20911759 |
|  | &nbsp;&nbsp; $2645984382 | &nbsp;&nbsp; $1113137282 | &nbsp;&nbsp; $— | &nbsp;&nbsp; $3759121664 |
| Derivative Financial Instruments<sup>(a)</sup>  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Liabilities  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Equity Contracts | &nbsp;&nbsp; $(64667)<br>| &nbsp;&nbsp; $— | &nbsp;&nbsp; $— | &nbsp;&nbsp; $(64667)<br>|

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

<sup>(a)</sup> Derivative financial instruments are futures contracts. Futures contracts are valued at the unrealized appreciation (depreciation) on the instrument.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | |
|:---|:---|
| **Portfolio Abbreviation** | **Portfolio Abbreviation** |
| NVS | Non-Voting Shares |

---

------

## Form NPORT-P: Monthly Portfolio Investments Report

### NPORT-P: Part A: General Information

**Item A.1. Information about the Registrant.**

- **a. Name of Registrant:** iShares Trust

- **b. Investment Company Act file number:** 811-09729

- **c. CIK number of Registrant:** 0001100663

- **d. LEI of Registrant:** 5493000860OXIC4B5K91

- **e. Address and telephone number of Registrant.**

  - **Street Address 1:** 400 Howard Street

  - **City:** San Francisco

  - **State:** CA

  - **Foreign country:** US

  - **Zip / Postal Code:** 94105

  - **Telephone number:** 800-474-2737

**Item A.2. Information about the Series.**

- **a. Name of Series:** iShares Global Healthcare ETF

- **b. EDGAR series identifier (if any):** S000004372

- **c. LEI of Series:** 5493008DMA8OZ7F0WV53

**Item A.3. Reporting period.**

- **a. Date of fiscal year-end:** 2026-03-31

- **b. Date as of which information is reported:** 2025-06-30

**Item A.4. Final filing**

Does the Fund anticipate that this will be its final filing on Form N-PORT? **No**

### Fund Information

**Total Assets:** $3787200838.23

**Total Liabilities:** $32871982.62

**Net Assets:** $3754328855.61

**Cash Not Reported:** $3616989.23

**Monthly Return Information**

| Class               | Month 1 Return (%)   | Month 2 Return (%)   | Month 3 Return (%)   |
|:---|:---|:---|:---|
| Class ID C000012102 | -2.10%               | -3.81%               | 1.30%                |

**Monthly Gains & Losses**

| Period   | Net Realized Gain/Loss   | Net Unrealized Appreciation/Depreciation   |
|:---|:---|:---|
| Month 1  | $1299530.28              | $-88336376.32                              |
| Month 2  | $40317637.26             | $-195091378.77                             |
| Month 3  | $-12349247.72            | $56877685.23                               |

### Schedule of Portfolio Investments

| Name                                           | Title                                                 | Identifiers                                   | Payoff Profile   | Asset Category   | Issuer Category   | Country   |   Balance | Units   | Value (USD)   | % of Net Assets   | Maturity Date   | Coupon Type   | Annualized Rate (%)   | Restricted?   |   Fair Value Level | Lending Status   |
|:---|:---|:---|:---|:---|:---|:---|---:|:---|:---|:---|:---|:---|:---|:---|---:|:---|
| Celltrion Inc                                  | Celltrion Inc                                         | CUSIP: 000000000<br>LEI: 988400JFZG785WJX3D68 | Long             | EC               | CORP              | KR        |     83103 | NS      | $9806148.48   | 0.26%             |  |  |  | No            |                  2 | On Loan: No      |
| Charles River Laboratories International Inc   | Charles River Laboratories International Inc          | CUSIP: 159864107<br>LEI: 549300BSQ0R4UZ5KX287 | Long             | EC               | CORP              | US        |     27688 | NS      | $4201100.24   | 0.11%             |  |  |  | No            |                  1 | On Loan: —       |
| Sigma Healthcare Ltd                           | Sigma Healthcare Ltd                                  | CUSIP: 000000000<br>LEI: 529900BZSP3BK7GYAO50 | Long             | EC               | CORP              | AU        |   3082980 | NS      | $6068215.93   | 0.16%             |  |  |  | No            |                  2 | On Loan: No      |
| Galderma Group AG                              | Galderma Group AG                                     | CUSIP: 000000000<br>LEI: 89450001OK6O8ELQ4584 | Long             | EC               | CORP              | CH        |     62457 | NS      | $9078479.77   | 0.24%             |  |  |  | No            |                  2 | On Loan: No      |
| BLACKROCK CASH FUNDS TREASURY SL AGENCY SHARES | BlackRock Cash Funds: Treasury, SL Agency Shares      | CUSIP: 066922477<br>LEI: 5493008LW2651I1QB503 | Long             | STIV             | RF                | US        |   5880000 | NS      | $5880000.00   | 0.16%             |  |  |  | No            |                  1 | On Loan: No      |
| Chugai Pharmaceutical Co Ltd                   | Chugai Pharmaceutical Co Ltd                          | CUSIP: 000000000<br>LEI: 529900T9LAII161DCN95 | Long             | EC               | CORP              | JP        |    340800 | NS      | $17795833.01  | 0.47%             |  |  |  | No            |                  2 | On Loan: No      |
| Viatris Inc                                    | Viatris Inc                                           | CUSIP: 92556V106<br>LEI: 254900ZZTSW7NL773X71 | Long             | EC               | CORP              | US        |    641810 | NS      | $5731363.30   | 0.15%             |  |  |  | No            |                  1 | On Loan: No      |
| Argenx SE                                      | Argenx SE                                             | CUSIP: 000000000<br>LEI: 7245009C5FZE6G9ODQ71 | Long             | EC               | CORP              | NL        |     32472 | NS      | $17975938.40  | 0.48%             |  |  |  | No            |                  2 | On Loan: No      |
| Vertex Pharmaceuticals Inc                     | Vertex Pharmaceuticals Inc                            | CUSIP: 92532F100<br>LEI: 54930015RAQRRZ5ZGJ91 | Long             | EC               | CORP              | US        |    137235 | NS      | $61097022.00  | 1.63%             |  |  |  | No            |                  1 | On Loan: No      |
| Johnson & Johnson                              | Johnson & Johnson                                     | CUSIP: 478160104<br>LEI: 549300G0CFPGEF6X2043 | Long             | EC               | CORP              | US        |   1289154 | NS      | $196918273.50 | 5.25%             |  |  |  | No            |                  1 | On Loan: No      |
| UnitedHealth Group Inc                         | UnitedHealth Group Inc                                | CUSIP: 91324P102<br>LEI: 549300GHBMY8T5GXDE41 | Long             | EC               | CORP              | US        |    486038 | NS      | $151629274.86 | 4.04%             |  |  |  | No            |                  1 | On Loan: No      |
| Cochlear Ltd                                   | Cochlear Ltd                                          | CUSIP: 000000000<br>LEI: 5493001OLLWY8KV5UC08 | Long             | EC               | CORP              | AU        |     34967 | NS      | $6915635.30   | 0.18%             |  |  |  | No            |                  2 | On Loan: No      |
| Revvity Inc                                    | Revvity Inc                                           | CUSIP: 714046109<br>LEI: 549300IKL1SDPFI7N655 | Long             | EC               | CORP              | US        |     65522 | NS      | $6337287.84   | 0.17%             |  |  |  | No            |                  1 | On Loan: No      |
| Straumann Holding AG                           | Straumann Holding AG                                  | CUSIP: 000000000<br>LEI: 50670046ML5FVIM60Z37 | Long             | EC               | CORP              | CH        |     63433 | NS      | $8302726.70   | 0.22%             |  |  |  | No            |                  2 | On Loan: No      |
| AbbVie Inc                                     | AbbVie Inc                                            | CUSIP: 00287Y109<br>LEI: FR5LCKFTG8054YNNRU85 | Long             | EC               | CORP              | US        |    946424 | NS      | $175675222.88 | 4.68%             |  |  |  | No            |                  1 | On Loan: No      |
| Universal Health Services Inc                  | Universal Health Services Inc                         | CUSIP: 913903100<br>LEI: 549300YGMGQDO0NMJD09 | Long             | EC               | CORP              | US        |     31607 | NS      | $5725608.05   | 0.15%             |  |  |  | No            |                  1 | On Loan: No      |
| Sonova Holding AG                              | Sonova Holding AG                                     | CUSIP: 000000000<br>LEI: 5299004A0QNX7FBNHS61 | Long             | EC               | CORP              | CH        |     26604 | NS      | $7933988.56   | 0.21%             |  |  |  | No            |                  2 | On Loan: No      |
| Olympus Corp                                   | Olympus Corp                                          | CUSIP: 000000000<br>LEI: 5299000Y52IFDI1I2A21 | Long             | EC               | CORP              | JP        |    604400 | NS      | $7179257.02   | 0.19%             |  |  |  | No            |                  2 | On Loan: No      |
| Thermo Fisher Scientific Inc                   | Thermo Fisher Scientific Inc                          | CUSIP: 883556102<br>LEI: HCHV7422L5HDJZCRFL38 | Long             | EC               | CORP              | US        |    202258 | NS      | $82007528.68  | 2.18%             |  |  |  | No            |                  1 | On Loan: No      |
| Agilent Technologies Inc                       | Agilent Technologies Inc                              | CUSIP: 00846U101<br>LEI: QUIX8Y7A2WP0XRMW7G29 | Long             | EC               | CORP              | US        |    152465 | NS      | $17992394.65  | 0.48%             |  |  |  | No            |                  1 | On Loan: No      |
| Cooper Cos Inc/The                             | Cooper Cos Inc/The                                    | CUSIP: 216648501<br>LEI: QJKMVPIGLH7530PCUE20 | Long             | EC               | CORP              | US        |    107206 | NS      | $7628778.96   | 0.20%             |  |  |  | No            |                  1 | On Loan: No      |
| Getinge AB                                     | Getinge AB                                            | CUSIP: 000000000<br>LEI: 5493003PZ4F570G3W735 | Long             | EC               | CORP              | SE        |    117132 | NS      | $2353267.10   | 0.06%             |  |  |  | No            |                  2 | On Loan: No      |
| DaVita Inc                                     | DaVita Inc                                            | CUSIP: 23918K108<br>LEI: M2XHYMU3TZNEZURC6H66 | Long             | EC               | CORP              | US        |     23513 | NS      | $3349426.85   | 0.09%             |  |  |  | No            |                  1 | On Loan: No      |
| Medtronic PLC                                  | Medtronic PLC                                         | CUSIP: 000000000<br>LEI: 549300GX3ZBSQWUXY261 | Long             | EC               | CORP              | IE        |    685286 | NS      | $59736380.62  | 1.59%             |  |  |  | No            |                  1 | On Loan: No      |
| Centene Corp                                   | Centene Corp                                          | CUSIP: 15135B101<br>LEI: 549300Z7JJ4TQSQGT333 | Long             | EC               | CORP              | US        |    264667 | NS      | $14366124.76  | 0.38%             |  |  |  | No            |                  1 | On Loan: No      |
| Zealand Pharma A/S                             | Zealand Pharma A/S                                    | CUSIP: 000000000<br>LEI: 549300ITBB1ULBL4CZ12 | Long             | EC               | CORP              | DK        |     34102 | NS      | $1912512.08   | 0.05%             |  |  |  | No            |                  2 | On Loan: —       |
| Genmab A/S                                     | Genmab A/S                                            | CUSIP: 000000000<br>LEI: 529900MTJPDPE4MHJ122 | Long             | EC               | CORP              | DK        |     35578 | NS      | $7388425.30   | 0.20%             |  |  |  | No            |                  2 | On Loan: No      |
| Roche Holding AG                               | Roche Holding AG                                      | CUSIP: 000000000<br>LEI: 549300U41AUUVOAAOB37 | Long             | EC               | CORP              | CH        |    376427 | NS      | $122873173.24 | 3.27%             |  |  |  | No            |                  2 | On Loan: No      |
| Zoetis Inc                                     | Zoetis Inc                                            | CUSIP: 98978V103<br>LEI: 549300HD9Q1LOC9KLJ48 | Long             | EC               | CORP              | US        |    239311 | NS      | $37320550.45  | 0.99%             |  |  |  | No            |                  1 | On Loan: No      |
| Siemens Healthineers AG                        | Siemens Healthineers AG                               | CUSIP: 000000000<br>LEI: 529900QBVWXMWANH7H45 | Long             | EC               | CORP              | DE        |    162764 | NS      | $9035737.43   | 0.24%             |  |  |  | No            |                  2 | On Loan: No      |
| Boston Scientific Corp                         | Boston Scientific Corp                                | CUSIP: 101137107<br>LEI: Y6ZDD9FP4P8JSSJMW954 | Long             | EC               | CORP              | US        |    792675 | NS      | $85141221.75  | 2.27%             |  |  |  | No            |                  1 | On Loan: No      |
| Zimmer Biomet Holdings Inc                     | Zimmer Biomet Holdings Inc                            | CUSIP: 98956P102<br>LEI: 2P2YLDVPES3BXQ1FRB91 | Long             | EC               | CORP              | US        |    106130 | NS      | $9680117.30   | 0.26%             |  |  |  | No            |                  1 | On Loan: No      |
| Otsuka Holdings Co Ltd                         | Otsuka Holdings Co Ltd                                | CUSIP: 000000000<br>LEI: N/A                  | Long             | EC               | CORP              | JP        |    280200 | NS      | $13892117.07  | 0.37%             |  |  |  | No            |                  2 | On Loan: No      |
| ResMed Inc                                     | ResMed Inc                                            | CUSIP: 761152107<br>LEI: 529900T3QE5253CCXF22 | Long             | EC               | CORP              | US        |     78490 | NS      | $20250420.00  | 0.54%             |  |  |  | No            |                  1 | On Loan: No      |
| Elevance Health Inc                            | Elevance Health Inc                                   | CUSIP: 036752103<br>LEI: 8MYN82XMYQH89CTMTH67 | Long             | EC               | CORP              | US        |    121055 | NS      | $47085552.80  | 1.25%             |  |  |  | No            |                  1 | On Loan: No      |
| Biogen Inc                                     | Biogen Inc                                            | CUSIP: 09062X103<br>LEI: W8J5WZB5IY3K0NDQT671 | Long             | EC               | CORP              | US        |     77941 | NS      | $9788610.19   | 0.26%             |  |  |  | No            |                  1 | On Loan: No      |
| Novo Nordisk A/S                               | Novo Nordisk A/S                                      | CUSIP: 000000000<br>LEI: 549300DAQ1CVT6CXN342 | Long             | EC               | CORP              | DK        |   1689190 | NS      | $117050745.86 | 3.12%             |  |  |  | No            |                  2 | On Loan: No      |
| Daiichi Sankyo Co Ltd                          | Daiichi Sankyo Co Ltd                                 | CUSIP: 000000000<br>LEI: 353800XGIU2IHQGC9504 | Long             | EC               | CORP              | JP        |   1019700 | NS      | $23624496.45  | 0.63%             |  |  |  | No            |                  2 | On Loan: No      |
| BlackRock Funds III                            | BlackRock Cash Funds: Institutional, SL Agency Shares | CUSIP: 066922519<br>LEI: 5493008LW2651I1QB503 | Long             | STIV             | RF                | US        |  15801557 | NS      | $15807877.30  | 0.42%             |  |  |  | No            |                  1 | On Loan: No      |
| Koninklijke Philips NV                         | Koninklijke Philips NV                                | CUSIP: 000000000<br>LEI: H1FJE8H61JGM1JSGM897 | Long             | EC               | CORP              | NL        |    426022 | NS      | $10229790.22  | 0.27%             |  |  |  | No            |                  2 | On Loan: No      |
| Sartorius AG                                   | Sartorius AG                                          | CUSIP: 000000000<br>LEI: 529900EQV2DY4FOAMU38 | Long             | EP               | CORP              | DE        |     13018 | NS      | $3315657.05   | 0.09%             |  |  |  | No            |                  2 | On Loan: No      |
| Insulet Corp                                   | Insulet Corp                                          | CUSIP: 45784P101<br>LEI: 549300TZTYD2PYN92D43 | Long             | EC               | CORP              | US        |     37485 | NS      | $11777037.30  | 0.31%             |  |  |  | No            |                  1 | On Loan: No      |
| Align Technology Inc                           | Align Technology Inc                                  | CUSIP: 016255101<br>LEI: 549300N5YSE0U3LCP840 | Long             | EC               | CORP              | US        |     37066 | NS      | $7017705.78   | 0.19%             |  |  |  | No            |                  1 | On Loan: No      |
| Becton Dickinson & Co                          | Becton Dickinson & Co                                 | CUSIP: 075887109<br>LEI: ICE2EP6D98PQUILVRZ91 | Long             | EC               | CORP              | US        |    153451 | NS      | $26431934.75  | 0.70%             |  |  |  | No            |                  1 | On Loan: No      |
| IQVIA Holdings Inc                             | IQVIA Holdings Inc                                    | CUSIP: 46266C105<br>LEI: 549300W3R20NM4KQPH86 | Long             | EC               | CORP              | US        |     89406 | NS      | $14089491.54  | 0.38%             |  |  |  | No            |                  1 | On Loan: No      |
| Moderna Inc                                    | Moderna Inc                                           | CUSIP: 60770K107<br>LEI: 549300EI6OKH5K5Q2G38 | Long             | EC               | CORP              | US        |    180977 | NS      | $4993155.43   | 0.13%             |  |  |  | No            |                  1 | On Loan: —       |
| Stryker Corp                                   | Stryker Corp                                          | CUSIP: 863667101<br>LEI: 5493002F0SC4JTBU5137 | Long             | EC               | CORP              | US        |    183532 | NS      | $72610765.16  | 1.93%             |  |  |  | No            |                  1 | On Loan: No      |
| M3 Inc                                         | M3 Inc                                                | CUSIP: 000000000<br>LEI: 3538001UOKRWIODYM055 | Long             | EC               | CORP              | JP        |    229200 | NS      | $3148451.91   | 0.08%             |  |  |  | No            |                  2 | On Loan: No      |
| GSK PLC                                        | GSK PLC                                               | CUSIP: 000000000<br>LEI: 5493000HZTVUYLO1D793 | Long             | EC               | CORP              | GB        |   2215702 | NS      | $42245583.50  | 1.13%             |  |  |  | No            |                  2 | On Loan: No      |
| Cigna Group/The                                | Cigna Group/The                                       | CUSIP: 125523100<br>LEI: 549300VIWYMSIGT1U456 | Long             | EC               | CORP              | US        |    143133 | NS      | $47316907.14  | 1.26%             |  |  |  | No            |                  1 | On Loan: No      |
| CVS Health Corp                                | CVS Health Corp                                       | CUSIP: 126650100<br>LEI: 549300EJG376EN5NQE29 | Long             | EC               | CORP              | US        |    676865 | NS      | $46690147.70  | 1.24%             |  |  |  | No            |                  1 | On Loan: No      |
| Astellas Pharma Inc                            | Astellas Pharma Inc                                   | CUSIP: 000000000<br>LEI: 529900IB708DY2HBBB35 | Long             | EC               | CORP              | JP        |    967075 | NS      | $9468583.64   | 0.25%             |  |  |  | No            |                  2 | On Loan: No      |
| Smith & Nephew PLC                             | Smith & Nephew PLC                                    | CUSIP: 000000000<br>LEI: 213800ZTMDN8S67S1H61 | Long             | EC               | CORP              | GB        |    467299 | NS      | $7156322.30   | 0.19%             |  |  |  | No            |                  2 | On Loan: No      |
| Eisai Co Ltd                                   | Eisai Co Ltd                                          | CUSIP: 000000000<br>LEI: 353800HDEE0ZYEX4QV91 | Long             | EC               | CORP              | JP        |    152600 | NS      | $4382735.68   | 0.12%             |  |  |  | No            |                  2 | On Loan: No      |
| Samsung Biologics Co Ltd                       | Samsung Biologics Co Ltd                              | CUSIP: 000000000<br>LEI: N/A                  | Long             | EC               | CORP              | KR        |      9855 | NS      | $7231772.38   | 0.19%             |  |  |  | No            |                  2 | On Loan: No      |
| Rede D'Or Sao Luiz SA                          | Rede D'Or Sao Luiz SA                                 | CUSIP: 000000000<br>LEI: N/A                  | Long             | EC               | CORP              | BR        |    576659 | NS      | $3759412.08   | 0.10%             |  |  |  | No            |                  1 | On Loan: No      |
| Incyte Corp                                    | Incyte Corp                                           | CUSIP: 45337C102<br>LEI: 549300Z4WN6JVZ3T4680 | Long             | EC               | CORP              | US        |     86355 | NS      | $5880775.50   | 0.16%             |  |  |  | No            |                  1 | On Loan: No      |
| Fresenius Medical Care AG                      | Fresenius Medical Care AG                             | CUSIP: 000000000<br>LEI: 549300CP8NY40UP89Q40 | Long             | EC               | CORP              | DE        |    107028 | NS      | $6149309.99   | 0.16%             |  |  |  | No            |                  2 | On Loan: No      |
| AstraZeneca PLC                                | AstraZeneca PLC                                       | CUSIP: 000000000<br>LEI: PY6ZZQWO2IZFZC3IOL08 | Long             | EC               | CORP              | GB        |    830819 | NS      | $115624361.69 | 3.08%             |  |  |  | No            |                  2 | On Loan: No      |
| Intuitive Surgical Inc                         | Intuitive Surgical Inc                                | CUSIP: 46120E602<br>LEI: 54930052SRG011710797 | Long             | EC               | CORP              | US        |    192037 | NS      | $104354826.17 | 2.78%             |  |  |  | No            |                  1 | On Loan: —       |
| Fresenius SE & Co KGaA                         | Fresenius SE & Co KGaA                                | CUSIP: 000000000<br>LEI: XDFJ0CYCOO1FXRFTQS51 | Long             | EC               | CORP              | DE        |    223629 | NS      | $11253636.32  | 0.30%             |  |  |  | No            |                  2 | On Loan: No      |
| Amgen Inc                                      | Amgen Inc                                             | CUSIP: 031162100<br>LEI: 62QBXGPJ34PQ72Z12S66 | Long             | EC               | CORP              | US        |    287096 | NS      | $80160074.16  | 2.14%             |  |  |  | No            |                  1 | On Loan: No      |
| Alcon AG                                       | Alcon AG                                              | CUSIP: 000000000<br>LEI: 549300LDT5AP8S0NBM78 | Long             | EC               | CORP              | CH        |    267053 | NS      | $23683039.21  | 0.63%             |  |  |  | No            |                  2 | On Loan: No      |
| Labcorp Holdings Inc                           | Labcorp Holdings Inc                                  | CUSIP: 504922105<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     44571 | NS      | $11700333.21  | 0.31%             |  |  |  | No            |                  1 | On Loan: No      |
| Ono Pharmaceutical Co Ltd                      | Ono Pharmaceutical Co Ltd                             | CUSIP: 000000000<br>LEI: 529900G26L4NG4GFJZ86 | Long             | EC               | CORP              | JP        |    248200 | NS      | $2689934.52   | 0.07%             |  |  |  | No            |                  2 | On Loan: No      |
| Abbott Laboratories                            | Abbott Laboratories                                   | CUSIP: 002824100<br>LEI: HQD377W2YR662HK5JX27 | Long             | EC               | CORP              | US        |    932190 | NS      | $126787161.90 | 3.38%             |  |  |  | No            |                  1 | On Loan: No      |
| Lonza Group AG                                 | Lonza Group AG                                        | CUSIP: 000000000<br>LEI: 549300EFW4H2TCZ71055 | Long             | EC               | CORP              | CH        |     38599 | NS      | $27604594.52  | 0.74%             |  |  |  | No            |                  2 | On Loan: No      |
| GE HealthCare Technologies Inc                 | GE HealthCare Technologies Inc                        | CUSIP: 36266G107<br>LEI: 549300OI9J7XOWZMUN85 | Long             | EC               | CORP              | US        |    244392 | NS      | $18102115.44  | 0.48%             |  |  |  | No            |                  1 | On Loan: No      |
| CSL Ltd                                        | CSL Ltd                                               | CUSIP: 000000000<br>LEI: 529900ECSECK5ZDQTE14 | Long             | EC               | CORP              | AU        |    258772 | NS      | $40875770.29  | 1.09%             |  |  |  | No            |                  2 | On Loan: No      |
| Sandoz Group AG                                | Sandoz Group AG                                       | CUSIP: 000000000<br>LEI: 5493000JWK6XWFEUD320 | Long             | EC               | CORP              | CH        |    235146 | NS      | $12886795.05  | 0.34%             |  |  |  | No            |                  2 | On Loan: No      |
| Dexcom Inc                                     | Dexcom Inc                                            | CUSIP: 252131107<br>LEI: 549300YSK3QDSFR5EU59 | Long             | EC               | CORP              | US        |    208800 | NS      | $18226152.00  | 0.49%             |  |  |  | No            |                  1 | On Loan: No      |
| Roche Holding AG                               | Roche Holding AG                                      | CUSIP: 000000000<br>LEI: 549300U41AUUVOAAOB37 | Long             | EC               | CORP              | CH        |     15482 | NS      | $5380476.46   | 0.14%             |  |  |  | No            |                  2 | On Loan: No      |
| Pfizer Inc                                     | Pfizer Inc                                            | CUSIP: 717081103<br>LEI: 765LHXWGK1KXCLTFYQ30 | Long             | EC               | CORP              | US        |   3046172 | NS      | $73839209.28  | 1.97%             |  |  |  | No            |                  1 | On Loan: No      |
| Hoya Corp                                      | Hoya Corp                                             | CUSIP: 000000000<br>LEI: 353800X4VR3BHEUCJB42 | Long             | EC               | CORP              | JP        |    184800 | NS      | $21947233.44  | 0.58%             |  |  |  | No            |                  2 | On Loan: No      |
| Bio-Techne Corp                                | Bio-Techne Corp                                       | CUSIP: 09073M104<br>LEI: 54930073RLKQ51TILZ35 | Long             | EC               | CORP              | US        |     83949 | NS      | $4319176.05   | 0.12%             |  |  |  | No            |                  1 | On Loan: No      |
| Molina Healthcare Inc                          | Molina Healthcare Inc                                 | CUSIP: 60855R100<br>LEI: 549300NQQCEQ46YHZ591 | Long             | EC               | CORP              | US        |     29578 | NS      | $8811286.20   | 0.23%             |  |  |  | No            |                  1 | On Loan: No      |
| UCB SA                                         | UCB SA                                                | CUSIP: 000000000<br>LEI: 2138008J191VLSGY5A09 | Long             | EC               | CORP              | BE        |     64388 | NS      | $12668839.88  | 0.34%             |  |  |  | No            |                  2 | On Loan: No      |
| Edwards Lifesciences Corp                      | Edwards Lifesciences Corp                             | CUSIP: 28176E108<br>LEI: YA13X31F3V31L8TMPR58 | Long             | EC               | CORP              | US        |    315204 | NS      | $24652104.84  | 0.66%             |  |  |  | No            |                  1 | On Loan: No      |
| Chicago Mercantile Exchange                    | XAV HEALTH CARE SEP25                                 | CUSIP: 000000000<br>LEI: SNZ2OJLFK8MNNCLQOF39 | N/A              | DE               |  | US        |       113 | NC      | $-64666.51    | -0.00%            |  |  |  | No            |                  1 | On Loan: No      |
| QIAGEN NV                                      | QIAGEN NV                                             | CUSIP: 000000000<br>LEI: 54930036WK3GMCN17Z57 | Long             | EC               | CORP              | NL        |    117031 | NS      | $5638510.47   | 0.15%             |  |  |  | No            |                  2 | On Loan: No      |
| Solventum Corp                                 | Solventum Corp                                        | CUSIP: 83444M101<br>LEI: 254900I70403OSGY4M28 | Long             | EC               | CORP              | US        |     74402 | NS      | $5642647.68   | 0.15%             |  |  |  | No            |                  1 | On Loan: —       |
| Cardinal Health Inc                            | Cardinal Health Inc                                   | CUSIP: 14149Y108<br>LEI: CCU46N3GJMF4OK4N7U60 | Long             | EC               | CORP              | US        |    129100 | NS      | $21688800.00  | 0.58%             |  |  |  | No            |                  1 | On Loan: No      |
| Cencora Inc                                    | Cencora Inc                                           | CUSIP: 03073E105<br>LEI: AI8GXW8LG5WK7E9UD086 | Long             | EC               | CORP              | US        |     92233 | NS      | $27656065.05  | 0.74%             |  |  |  | No            |                  1 | On Loan: No      |
| Bayer AG                                       | Bayer AG                                              | CUSIP: 000000000<br>LEI: 549300J4U55H3WP1XT59 | Long             | EC               | CORP              | DE        |    525034 | NS      | $15817859.90  | 0.42%             |  |  |  | No            |                  2 | On Loan: No      |
| Sanofi SA                                      | Sanofi SA                                             | CUSIP: 000000000<br>LEI: 549300E9PC51EN656011 | Long             | EC               | CORP              | FR        |    571514 | NS      | $55330417.28  | 1.47%             |  |  |  | No            |                  2 | On Loan: No      |
| Merck KGaA                                     | Merck KGaA                                            | CUSIP: 000000000<br>LEI: 529900OAREIS0MOPTW25 | Long             | EC               | CORP              | DE        |     69070 | NS      | $8955506.11   | 0.24%             |  |  |  | No            |                  2 | On Loan: No      |
| Sysmex Corp                                    | Sysmex Corp                                           | CUSIP: 000000000<br>LEI: 5299001ZO4CKWACMZI55 | Long             | EC               | CORP              | JP        |    260000 | NS      | $4525873.17   | 0.12%             |  |  |  | No            |                  2 | On Loan: No      |
| EssilorLuxottica SA                            | EssilorLuxottica SA                                   | CUSIP: 000000000<br>LEI: 549300M3VH1A3ER1TB49 | Long             | EC               | CORP              | FR        |    154036 | NS      | $42297163.13  | 1.13%             |  |  |  | No            |                  2 | On Loan: No      |
| Haleon PLC                                     | Haleon PLC                                            | CUSIP: 000000000<br>LEI: 549300PSB3WWEODCUP19 | Long             | EC               | CORP              | GB        |   4815178 | NS      | $24748213.69  | 0.66%             |  |  |  | No            |                  2 | On Loan: No      |
| HCA Healthcare Inc                             | HCA Healthcare Inc                                    | CUSIP: 40412C101<br>LEI: 529900PH4ZGUH2MNEU89 | Long             | EC               | CORP              | US        |     92806 | NS      | $35553978.60  | 0.95%             |  |  |  | No            |                  1 | On Loan: No      |
| Terumo Corp                                    | Terumo Corp                                           | CUSIP: 000000000<br>LEI: 353800JX1R4582QVK932 | Long             | EC               | CORP              | JP        |    791200 | NS      | $14519994.93  | 0.39%             |  |  |  | No            |                  2 | On Loan: No      |
| Takeda Pharmaceutical Co Ltd                   | Takeda Pharmaceutical Co Ltd                          | CUSIP: 000000000<br>LEI: 549300ZLMVP4X0OGR454 | Long             | EC               | CORP              | JP        |    850092 | NS      | $26244875.62  | 0.70%             |  |  |  | No            |                  2 | On Loan: No      |
| McKesson Corp                                  | McKesson Corp                                         | CUSIP: 58155Q103<br>LEI: 549300WZWOM80UCFSF54 | Long             | EC               | CORP              | US        |     66976 | NS      | $49078673.28  | 1.31%             |  |  |  | No            |                  1 | On Loan: No      |
| Humana Inc                                     | Humana Inc                                            | CUSIP: 444859102<br>LEI: 529900YLDW34GJAO4J06 | Long             | EC               | CORP              | US        |     64472 | NS      | $15762114.56  | 0.42%             |  |  |  | No            |                  1 | On Loan: No      |
| Pro Medicus Ltd                                | Pro Medicus Ltd                                       | CUSIP: 000000000<br>LEI: N/A                  | Long             | EC               | CORP              | AU        |     29211 | NS      | $5466389.71   | 0.15%             |  |  |  | No            |                  2 | On Loan: No      |
| Eurofins Scientific SE                         | Eurofins Scientific SE                                | CUSIP: 000000000<br>LEI: 529900JEHFM47DYY3S57 | Long             | EC               | CORP              | LU        |     68999 | NS      | $4917235.93   | 0.13%             |  |  |  | No            |                  2 | On Loan: No      |
| Danaher Corp                                   | Danaher Corp                                          | CUSIP: 235851102<br>LEI: S4BKK9OTCEWQ3YHPFM11 | Long             | EC               | CORP              | US        |    342032 | NS      | $67565001.28  | 1.80%             |  |  |  | No            |                  1 | On Loan: No      |
| Regeneron Pharmaceuticals Inc                  | Regeneron Pharmaceuticals Inc                         | CUSIP: 75886F107<br>LEI: 549300RCBFWIRX3HYQ56 | Long             | EC               | CORP              | US        |     56225 | NS      | $29518125.00  | 0.79%             |  |  |  | No            |                  1 | On Loan: No      |
| Shionogi & Co Ltd                              | Shionogi & Co Ltd                                     | CUSIP: 000000000<br>LEI: 35380049VXDTHZI3DY35 | Long             | EC               | CORP              | JP        |    431000 | NS      | $7758980.67   | 0.21%             |  |  |  | No            |                  2 | On Loan: No      |
| Grifols SA                                     | Grifols SA                                            | CUSIP: 000000000<br>LEI: 959800HSSNXWRKBK4N60 | Long             | EC               | CORP              | ES        |    154655 | NS      | $1887097.35   | 0.05%             |  |  |  | No            |                  2 | On Loan: No      |
| Sartorius Stedim Biotech                       | Sartorius Stedim Biotech                              | CUSIP: 000000000<br>LEI: 52990006IVXY7GCSSR39 | Long             | EC               | CORP              | FR        |     14087 | NS      | $3370490.70   | 0.09%             |  |  |  | No            |                  2 | On Loan: No      |
| Novartis AG                                    | Novartis AG                                           | CUSIP: 000000000<br>LEI: 5493007HIVTX6SY6XD66 | Long             | EC               | CORP              | CH        |   1018636 | NS      | $123639079.79 | 3.29%             |  |  |  | No            |                  2 | On Loan: No      |
| Mettler-Toledo International Inc               | Mettler-Toledo International Inc                      | CUSIP: 592688105<br>LEI: 5493000BD5GJNUDIUG10 | Long             | EC               | CORP              | US        |     11176 | NS      | $13128670.72  | 0.35%             |  |  |  | No            |                  1 | On Loan: No      |
| Sonic Healthcare Ltd                           | Sonic Healthcare Ltd                                  | CUSIP: 000000000<br>LEI: 549300NQQ5L2NONWR862 | Long             | EC               | CORP              | AU        |    257356 | NS      | $4542638.54   | 0.12%             |  |  |  | No            |                  2 | On Loan: No      |
| Merck & Co Inc                                 | Merck & Co Inc                                        | CUSIP: 58933Y105<br>LEI: 4YV9Y5M8S0BRK1RP0397 | Long             | EC               | CORP              | US        |   1345390 | NS      | $106501072.40 | 2.84%             |  |  |  | No            |                  1 | On Loan: No      |
| Coloplast A/S                                  | Coloplast A/S                                         | CUSIP: 000000000<br>LEI: 529900NN7SOJ5QG82X67 | Long             | EC               | CORP              | DK        |     66672 | NS      | $6347369.14   | 0.17%             |  |  |  | No            |                  2 | On Loan: No      |
| Quest Diagnostics Inc                          | Quest Diagnostics Inc                                 | CUSIP: 74834L100<br>LEI: 8MCWUBXQ0WE04KMXBX50 | Long             | EC               | CORP              | US        |     59321 | NS      | $10655831.23  | 0.28%             |  |  |  | No            |                  1 | On Loan: No      |
| STERIS PLC                                     | STERIS PLC                                            | CUSIP: 000000000<br>LEI: N/A                  | Long             | EC               | CORP              | IE        |     52508 | NS      | $12613471.76  | 0.34%             |  |  |  | No            |                  1 | On Loan: No      |
| West Pharmaceutical Services Inc               | West Pharmaceutical Services Inc                      | CUSIP: 955306105<br>LEI: 5493007NKRGM1RJQ1P16 | Long             | EC               | CORP              | US        |     38896 | NS      | $8510444.80   | 0.23%             |  |  |  | No            |                  1 | On Loan: No      |
| Waters Corp                                    | Waters Corp                                           | CUSIP: 941848103<br>LEI: 5T547R1474YC9HOD8Q74 | Long             | EC               | CORP              | US        |     31731 | NS      | $11075388.24  | 0.30%             |  |  |  | No            |                  1 | On Loan: No      |
| Eli Lilly & Co                                 | Eli Lilly & Co                                        | CUSIP: 532457108<br>LEI: FRDRIPF3EKNDJ2CQJL29 | Long             | EC               | CORP              | US        |    421090 | NS      | $328252287.70 | 8.74%             |  |  |  | No            |                  1 | On Loan: No      |
| Henry Schein Inc                               | Henry Schein Inc                                      | CUSIP: 806407102<br>LEI: VGO3WGL8H45T73F4RR92 | Long             | EC               | CORP              | US        |     67107 | NS      | $4902166.35   | 0.13%             |  |  |  | No            |                  1 | On Loan: —       |
| IDEXX Laboratories Inc                         | IDEXX Laboratories Inc                                | CUSIP: 45168D104<br>LEI: OGMTXK0LUU1HKV2P0J84 | Long             | EC               | CORP              | US        |     43761 | NS      | $23470774.74  | 0.63%             |  |  |  | No            |                  1 | On Loan: —       |
| Hologic Inc                                    | Hologic Inc                                           | CUSIP: 436440101<br>LEI: 549300DYP6F5ZJL0LB74 | Long             | EC               | CORP              | US        |    119259 | NS      | $7770916.44   | 0.21%             |  |  |  | No            |                  1 | On Loan: No      |
| Baxter International Inc                       | Baxter International Inc                              | CUSIP: 071813109<br>LEI: J5OIVXX3P24RJRW5CK77 | Long             | EC               | CORP              | US        |    271701 | NS      | $8227106.28   | 0.22%             |  |  |  | No            |                  1 | On Loan: No      |
| Bristol-Myers Squibb Co                        | Bristol-Myers Squibb Co                               | CUSIP: 110122108<br>LEI: HLYYNH7UQUORYSJQCN42 | Long             | EC               | CORP              | US        |   1090379 | NS      | $50473643.91  | 1.34%             |  |  |  | No            |                  1 | On Loan: No      |
| Gilead Sciences Inc                            | Gilead Sciences Inc                                   | CUSIP: 375558103<br>LEI: 549300WTZWR07K8MNV44 | Long             | EC               | CORP              | US        |    666036 | NS      | $73843411.32  | 1.97%             |  |  |  | No            |                  1 | On Loan: No      |

### Signature

**Date Signed:** 2025-07-31

**Name of Applicant:** iShares Trust

**Signature:** Chuck Pulsfort

**Name of Signer:** Chuck Pulsfort

**Title:** Assistant Treasurer